935467-20-2

Basic information

• Product Name: C₁₅H₂₁NO₂
• Synonyms: C₁₅H₂₁NO₂
• CAS NO: 935467-20-2
• Molecular Weight: 247.337
• Mol File: 935467-20-2.mol

Chemical Properties

• CAS DataBase Reference: C₁₅H₂₁NO₂(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₅H₂₁NO₂(935467-20-2)
• EPA Substance Registry System: C₁₅H₂₁NO₂(935467-20-2)

Safety Data

• Hazardous Substances Data: 935467-20-2(Hazardous Substances Data)

Upstream product

• 78-82-0 Isobutyronitrile 
• 4541-14-4 4-benzyloxy-butan-1-ol 
• 5470-84-8 4-benzyloxybutanal 

Downstream Products

• 935467-21-3 C₂₄H₄₁NO₂Si 
• 935467-22-4 C₂₄H₄₅NO₂Si 
• 935467-23-5 C₂₅H₄₅NO₃Si 

Relevant articles and documents

COMBINATION THERAPIES WITH FARNESOID X RECEPTOR (FXR) MODULATORS

Described herein are methods of treating a metabolic disorder in an individual in need thereof, comprising co-administering to the individual a therapeutically effective amount of an FXR modulator, and at least one second agent that is an CCR2/CCR5 antagonist, ASKl inhibitor, DPP-IV inhibitor, caspase protease inhibitor, SGLT2 inhibitor, acetyl-CoA carboxylase (ACC) inhibitor, diacyl glycerol acyltransferase-1 inhibitor, sodium -bile acid cotransporter-inhibitor, TLR-4 antagonist, PPAR alpha/delta agonist, or GLP-1 agonist, or a combination thereof.

Synthesis of a highly functionalised azepine via a new TBSOTf-mediated cyclisation of a terminal formamide

The synthesis of a highly functionalised azepine which can be further derivatised by common chemical transformations is described herein. The present synthesis comprises high-yielding reaction steps and features a new method for the synthesis of azepines via TBSOTf-mediated cyclisation of terminal formamides. Georg Thieme Verlag Stuttgart.